Role of genomic factors on late adverse events after lymphoma
Recruiting
- Conditions
- Non-Hodgkin lymphomaHodgkin lymphoma100253191008220610027656
- Registration Number
- NL-OMON52606
- Lead Sponsor
- ederlands Kanker Instituut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 5000
Inclusion Criteria
- 5-years survivors of Hodgkin lymphoma (HL) or diffuse large B-cell
non-Hodgkin lymphoma (DLBCL)
- Age at HL/DLBCL diagnosis between 15 and 60 years
- Treated at one of the participating BETER centers
- Living survivors: written informed consent
Exclusion Criteria
we will exclude survivors who have previously indicated at the BETER clinic
that they do not want to be approached for (further) research (less than 2% of
the BETER population).
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method